Price $10.83 |
Market Cap
434.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.96
|
P/S
1.63
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
6.6K
|
FCF
0.0
|
|
Op. Margin
-2.80%
|
Net Margin
18.30%
|
ROE
8.60%
|
ROI
-33.50%
|
|
ROA
7.20%
|
EPS Growth
-19.70%
|
Current Ratio
3.0
|
Debt/Equity
8.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $7.00 | - | - | 244.5M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.26 | - | - | 1.2B | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.91 | - | - | 26.9M | Strong Buy |
| CytomX Therapeutics Inc (CTMX) | $6.57 | - | - | 319.2M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $2.45 | - | - | 12M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
